Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

and wealth influence the likelihood of developing cognitive impairment or dementia in later life and whether a person is likely to recover, finds ... Oct. 31, 2024 — A drug commonly used to ...

In this prognostic study, with the use of a statistical modeling approach, the Florey Dementia Index was developed and validated to predict the onset age of mild cognitive impairment and Alzheimer ...

The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing ...